User contributions for Tejasvi Aryaputra

7 February 2023

• 23:0723:07, 7 February 2023 diff hist +15,078‎ Lybalvi (Olanzapine and Samidorphan) ‎No edit summary current

20 January 2023

• 17:0117:01, 20 January 2023 diff hist +3,741‎ N Lybalvi (Olanzapine and Samidorphan) ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Lybalvi |aOrAn=a |drugClass=combination of olanzapine, an atypical antipsychotic, and samidorphan, an opioid antagonist |indicationType=treatment |indication=schizophrenia and certain aspects of bipolar I disorder |hasBlackBoxWarning=Yes |adverseReactions=somnolence, headache, [[dry mouth], and weight increase for patients with schizophrenia. Dizziness, asthenia, constipation, [..."
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Package Insert Pt.2.png ‎No edit summary current
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Package Insert Pt.1.png ‎No edit summary current
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Drug Label 2.png ‎No edit summary current
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Drug Label 1.png ‎No edit summary current
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Drug Info.png ‎No edit summary current
• 16:1016:10, 20 January 2023 diff hist 0‎ N File:Structure 2.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Structure 1.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Table 5 Clinical Data Trial 3.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Table 4 Clinical Data Trial 1 and 2.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Table 3 Coadmininstered Drugs.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Table 2 Adverse Reaction Trial 3.png ‎No edit summary current
• 16:0916:09, 20 January 2023 diff hist 0‎ N File:Ibrexafungerp Table 1 Adverse Reactions (Trials 1 and 2).png ‎No edit summary current
• 15:5115:51, 20 January 2023 diff hist +5,623‎ Ibrexafungerp ‎No edit summary current

18 January 2023

• 06:0006:00, 18 January 2023 diff hist +4,749‎ Ibrexafungerp ‎No edit summary
• 04:5604:56, 18 January 2023 diff hist +2,856‎ Aducanumab-avwa ‎No edit summary current
• 04:5404:54, 18 January 2023 diff hist +2,211‎ Aducanumab-avwa ‎No edit summary

11 January 2023

• 05:4805:48, 11 January 2023 diff hist +8,233‎ N Ibrexafungerp ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Ibrexafungerp |aOrAn=a |drugClass=triterpenoid antifungal |indicationType=treatment |indication=vulvovaginal candidiasis |hasBlackBoxWarning=Yes |adverseReactions=nausea, dizziness, diarrhea, vomiting, and abdominal pain |blackBoxWarningTitle='''<span style="color:#FF0000;">RISK OF EMBRYO-FETAL TOXICITY</span>''' |blackBoxWarningBody=<BR> *BREXAFEMME is contraindicated in pregn..."

10 January 2023

• 21:5921:59, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 8 Study 2 Biomarkers.png ‎No edit summary current
• 21:5921:59, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 7 Clinical Results Study 1.png ‎No edit summary current
• 21:5921:59, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 6 Study 1 Biomarkers.png ‎No edit summary current
• 21:5921:59, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 5 Adverse Reactions.png ‎No edit summary current
• 21:5921:59, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 4 ARIA Classification.png ‎No edit summary current
• 21:5821:58, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 3 Dosing Modifciations.png ‎No edit summary current
• 21:5821:58, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 2 Dosing Monitoring.png ‎No edit summary current
• 21:5821:58, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Table 1 Dosing.png ‎No edit summary current
• 21:5821:58, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Study 3 Biomarkers.png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Package Insert Cont..png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Package Insert.png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Figure 4 Clinical Studies.png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Figure 3 Clinical Studies.png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Figure 2 Clinical Studies.png ‎No edit summary current
• 21:5721:57, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Figure 1 Clinical Studies.png ‎No edit summary current
• 21:5621:56, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Drug Label (3 mL).png ‎No edit summary current
• 21:5621:56, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Drug Label (1.7 mL).png ‎No edit summary current
• 21:5621:56, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Drug Cont..png ‎No edit summary current
• 21:5621:56, 10 January 2023 diff hist 0‎ N File:Aducanumab-avwa Drug Info .png ‎No edit summary current

5 January 2023

• 17:3117:31, 5 January 2023 diff hist +1‎ Aducanumab-avwa ‎No edit summary
• 17:2917:29, 5 January 2023 diff hist +18,474‎ N Aducanumab-avwa ‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Tejasvi Aryaputra |genericName=Aducanumab-avwa |aOrAn=an |drugClass=amyloid beta-directed antibody |indicationType=treatment |indication=treat Alzheimer’s disease |adverseReactions=ARIA-H microhemorrhage, fall, ARIA-Edema, ARIA-H superficial siderosis, and headache |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>..."
• 05:4305:43, 5 January 2023 diff hist +2,942‎ Asparaginase erwinia chrysanthemi (recombinant)-rywn ‎No edit summary current

3 January 2023

• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Table 5 Clinical Studies.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Table 4 Pharmacokinetics.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Table 3 Adverse Reactions.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Table 2 Dosage Modifications.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Table 1 Dosages.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Drug Label 2.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Drug Label 1.png ‎No edit summary current
• 13:4613:46, 3 January 2023 diff hist 0‎ N File:Rylaze Drug Insert.png ‎No edit summary current
• 13:3613:36, 3 January 2023 diff hist +84‎ Asparaginase erwinia chrysanthemi (recombinant)-rywn ‎No edit summary